Human genetic technologies, European governance and the politics of bioethics

Nature Reviews Genetics

Volumn 3, Issue 10, 2002, Pages 808-814

  Salter, Brian ^a   Jones, Mavis ^a  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ETHICS; EUROPE; FOOD BIOTECHNOLOGY; GENETICALLY MODIFIED CROP; GOVERNMENT; HUMAN; HUMAN GENETICS; NONHUMAN; PLANT BIOTECHNOLOGY; POLITICS; PRIORITY JOURNAL; REVIEW;

BIOETHICS AND PROFESSIONAL ETHICS; EUROPEAN GROUP ON ETHICS IN SCIENCE AND NEW TECHNOLOGIES; GENETICS AND REPRODUCTION;

BIOETHICS; BIOTECHNOLOGY; EUROPE; EUROPEAN UNION; GENETICS; HUMANS; POLITICS;

EID: 0036788275     PISSN: 14710056     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrg912     Document Type: Review

References (47)

1. European Commission. Life Sciences and Biotechnology - a Strategy for Europe COM(2002)27 Final (Brussels) [online] (cited 4/9/02) 〈http://europa.eu.int/eurlex/en/com/cnc/2002/com2002_0027en01.pdf〉 (2002)
2. Franklin, S. What we know and what we don't about cloning and society. New Genet. Soc. 18, 111-120 (1999).
3. Beck, U. World Risk Society (Polity, Cambridge, UK, 1999).
4. Giddens, A. The Consequences of Modernity (Stanford Univ. Press, California, 1990).
5. Frewer, L. J. & Salter, B. Public attitudes, scientific advice and the politics of regulatory policy: the case of BSE. Sci. Public Policy 29, 137-145 (2002).
6. Grove-White, R. Afterword: On 'Sound Science', the environment, and political authority. Environ. Values 8, 277-282 (1999).
7. Reinicke, W. H. The other world wide web: global public policy networks. Foreign Policy 117, 44-53 (1999).
8. Richardson, J. Government, interest groups and policy change. Polit. Stud. 48, 1006-1025 (2000).
9. Irwin, A. Citizen Science: A Study of People, Expertise and Sustainable Development (Routledge, London, 1995)
10. Global Lawyers and Physicians Working Together for Human Rights. Database of Global Policies on Human Cloning and Germ-line Engineering [online] (cited 4/9/02) 〈http://www.glphr.org/genetic/genetic.htm〉 (2002)
11. The President's Council on Bioethics. [online] (cited 4/9/02) 〈http://bioethics.gov〉 2001
12. Health Canada. Reproductive and Genetic Technologies [onlinel (cited 4/9/02) 〈http://www.hcsc.gc.ca/english/protection/biologics_genetics/ reproduction/rgt/workbook.htm#hum〉 2000
13. Royal Commission on New Reproductive Technologies. Proceed with Care. Final Report of the Royal Commission on New Reproductive Technologies (Canada Communications Group, Ottawa, 1993).
14. Reich, W. T. (ed.) in The Encyclopedia of Bioethics Revised Edn (Simon & Schuster-Macmillan, New York, 1995).
15. Jonsen, A. R. The Birth of Bioethics (Oxford Univ. Press, New York, 1998).
16. Gbadegesin, S. in A Companion to Bioethics (ed. Kuhse, H. & Singer, P.) 24-31 (Blackwell, Oxford, UK, 1998).
17. Callahan, D. The social sciences and the task of bioethics. Daedelus (Bioethics & Beyond Suppl.) 128, 253-274 (1999).
18. Levidow, L., Carr, S. & Wield, D. Genetically modified crops in the European Union: regulatory conflicts as precautionary opportunities J. Risk Res. 3, 189-208 (2000).
19. Van Ommen, G. J. B. The Future Directions of Human Genome Research in Europe. Florence strategy meeting, Human Genome Organisation, Florence [online] (cited 4/9/02) 〈http://europa.eu.int/comm/research/biomed/florence-hgr-rep.pdf〉 (1999)
20. Abraham, J. & Lewis, G. Regulating Medicines in Europe (Routledge, London, 2000).
21. Abraham, J. & Lewis, G. Harmonising and competing for medicine's regulation: how healthy are the European Union's systems of drug approval. Social Sci. Med. 48, 1655-1667 (1999).
22. Hooghe, L. & Marks, G. Multi-level Governance and European Integration (Rowman & Littlefield Publ., Lanham, Maryland, 2001).
23. Marks, G. & McAdam, D. Social movements and the changing structure of political opportunity in the European Community. West Euro. Polit. 19, 249-278 (1996).
24. Scully, R. The EP and the co-decision procedure: a reassessment. J. Legislative Stud. 3, 58-73 (1997).
25. Marks, G., Scharpf, F., Schmitter, P. & Streeck, W. Governance in the Emerging European Union (Sage, London, 1996).
26. European Parliament. Resolution on the ethical and legal problems of genetic engineering. Official J. C 096, 171 (1989).
27. Van Heyningen, V. & Cox, D. R. Advice to governments: scientific give and take. Nature Rev. Genet. 3, 631-635 (2002).
28. European Commission. Amended proposals for Council decision concern the specific programmes implementing the 6th Framework Programme of the European Community for research, technological development and demonstration activities 2002-2006 COM(2002)43 Final, 30.22.2002 (Brussels) [online] (cited 9/9/02) 〈http://europa.eu.int/eurlex/en/com/pdf/2002/en.502PC0043.01.pdf〉 (2002).
29. UNESCO. Universal declaration on the human genome and human rights adopted by the General Conference of UNESCO at its 29th Session, 11 November 1997 [online] (cited 4/9/02) 〈http://www.unesco.org/ibc〉 (1997).
30. UNESCO. Why do we need a declaration on the human genome? General Conference 1997 [online] (cited 4/9/02) 〈http://www.unesco.org/ope/29gencom/ewhy.htm〉 (1997).
31. Council of Europe. Convention on Human Rights and Biomedicine (Council of Europe, Strasbourg, 1997).
32. Gottweis, H, German politics of genetic engineering and its deconstruction Social Stud. Sci. 25, 195-235 (1995).
33. Group of Advisers on the Ethical Implications of Biotechnology. Gene Therapy Opinion no. 4 (Group of Advisers, Brussels, 1994) [online] (cited 4/9/02) 〈http://europa.eu.int/comm/european_group_ethics/gaieb/en/ opinion4.pdf〉 (1994).
34. Group of Advisers on the Ethical Implications of Biotechnology. Ethical Aspects of Prenatal Diagnosis Opinion no, 5 (Group of Advisers, Brussels, 1995) [online] (cited 4/9/02) 〈http://europe.eu.int/comm/european_group_ethics/gaieb/en/ opinion6.pdf〉 (1995).
35. Group of Advisers on the Ethical Implications of Biotechnology. The Patenting of Inventions Involving Elements of Human Origin Opinion no, 8 (Group of Advisers, Brussels, 1996) [online] (cited 4/9/02) 〈http://europe.eu.int/comm/european_group_ethics/gaieb/en/ opinion8.pdf〉 (1996).
36. Group of Advisers on the Ethical Implications of Biotechnology. Ethical Aspects of the Genetic Modification of Animals Opinion no. 7 (Group of Advisers, Brussells, 1996) [online] (cited 4/9/02) 〈http://europe.eu.int/comm/european_group_ethics/gaieb/en/ opinion7.pdf〉 (1996).
37. Group of Advisers on the Ethical Implications of Biotechnology. The Cloning Techniques Opinion no. 9 (Group of Advisers, Brussels, 1997) [online] (cited 4/9/02) 〈http://europe.eu.int/comm/european_group_ethics/gaieb/en/ opinion9.pdf〉 (1997).
38. European Group on Ethics in Science and New Technologies. Human Tissue Banking Opinion to the European Commission (EGE, Brussels, 1998) [online] (cited 4/9/02) 〈http://europa.eu.int/comm/european_group_ethics/gaieb/en/ opinion11.pdf〉 (1998).
39. European Group on Ethics in Science and New Technologies. The Ethical Aspects of Patenting Inventions Involving Human Stem Cells Opinion to the European Commission (EGE, Brussels, 2002) [online] (cited 4/9/02) 〈http://europa.eu.int/comm/european_group_ethics/gaieb/en/ opinion16.pdf〉 (2002).
40. European Group on Ethics in Science and New Technologies. General Report of the Activities of the European Group on Ethics, 1998-2000, no. 10 (Brussels, 2001) [online] (cited 4/9/02) 〈http://europa.eu.int/comm/european_group_ethics/ publications_en.htm〉 (2001).
41. European Group on Ethics in Science and New Technologies. General Report of the Activities of the European Group on Ethics, 1998-2000, no. 12 (Brussels, 2001) [online] (cited 4/9/02) 〈http://europa.eu.int/comm/european_group_ethics/ publications-en.htm〉 2001.
42. European Group on Ethics in Science and New Technologies, Citizen Rights and New Technologies: a European Challenge (Brussels, 2000) [online] (cited 4/9/02) 〈http://europa.eu.int/comm/secretariat_general/sgc/ethics/eu/ index.htm〉 (2000).
43. European Group on Ethics in Science and New Technologies. Ethical Aspects of Research Involving the Use of Human Embryos in the Context of the 5th Framework Programme Opinion no. 12 to the European Commission (1998). [online] (cited 9/9/02) 〈http://euro-eu-int/comm/europeangroup ethics/docs/avis12_en.pdf〉 (1998).
44. European Council. Council Decision 1999/167/EC adopting a Specific Programme for Research, Technological Development and Demonstration on Quality of Life and Management of Living Resources, 1998-2002. Offical J. L 64, 1-19 (1999).
45. European Group on Ethics in Science and New Technologies. General Report of the Activities of the European Group on Ethics, 1998-2000 (Brussels, 2001). [onlinel (cited 9/9/02) 〈http://europa.eu.int/comm/european_group_ethics/doc s/rap_en.pdf〉 (2001).
46. European Group on Ethics in Science and New Technologies. General Report of the Activities of the European Group on Ethics, 1998-2000, no. 2 (Brussels, 2001) [online] (cited 4/9/02) 〈http://europa.eu.int/comm/european_group_ethics/ publications_en.htm〉 (2001).
47. Marris, C., Wynne, B., Simmons, P. & Weldon, S. Public Perceptions of Agricultural Biotechnologies in Europe Final report of the PABE research project, funded by the Commission of European Communities, contract number: FAIR CT98-3844 (DG12-SSMI) 〈http://www.pabe.net〉 (2001).